U.S. Crackdown on Chinese Biotech Could Harm Patients by Lilu Anderson 22.06.2024 America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
Congressional Plans for WuXi: Implications for Biotech by Lilu Anderson 29.03.2024 Stay updated on the latest in biotech with our newsletter and podcast. Boundless becomes the ninth biotech company to go ...
US Lawmakers Move to Restrict Chinese Biotech Firms by Lilu Anderson 19.02.2024 Lawmakers in the US are looking to bar Chinese biotech companies due to concerns about competition and national security. The ...